Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Friday, 15'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
10:46am, Thursday, 14'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:51pm, Wednesday, 13'th Nov 2024
Globus Medical (GMED) possesses solid growth attributes, which could help it handily outperform the market.
Expanding Global Market, NuVasive Benefits to Aid GMED Stock
12:05pm, Wednesday, 13'th Nov 2024
Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
GMED or SONVY: Which Is the Better Value Stock Right Now?
12:45pm, Tuesday, 12'th Nov 2024
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best optio
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy?
10:45am, Monday, 11'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GMED Q3 Earnings Top, '24 Guidance Raised, Stock Gains in Aftermarket
08:35am, Wednesday, 06'th Nov 2024
Globus Medical delivers massive sales and earnings growth in the third quarter of 2024. However, margins contract.
Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript
08:12pm, Tuesday, 05'th Nov 2024
Globus Medical, Inc. (NYSE:GMED ) Q3 2024 Earnings Conference Call November 5, 2024 6:00 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO
Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
07:00pm, Tuesday, 05'th Nov 2024
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Stre
Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates
06:25pm, Tuesday, 05'th Nov 2024
Globus Medical (GMED) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.57 per share a year ago.
Globus Medical Reports Third Quarter 2024 Results
04:15pm, Tuesday, 05'th Nov 2024
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 3
LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud
11:00am, Sunday, 03'rd Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical
Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics
10:20am, Thursday, 31'st Oct 2024
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the
